Fidelity Investments’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Fidelity Investments’s Portfolio PRNB Stock Details PRNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-4,956,097	Closed	-$296M	–	4162
2020 Q2	$296M	Buy	4,956,097 +4,832	+0.1%	+$298K	0.03%	465
2020 Q1	$294M	Buy	4,951,265 +33,333	+0.7%	+$1.94M	0.04%	390
2019 Q4	$269M	Buy	4,917,932 +1,322,370	+37%	+$49.4M	0.03%	539
2019 Q3	$102M	Buy	3,595,562 +15,594	+0.4%	+$572K	0.01%	883
2019 Q2	$119M	Buy	3,579,968 +180	+0%	+$5.62K	0.01%	848
2019 Q1	$122M	Buy	3,579,788 +2,437,717	+213%	+$77.5M	0.01%	824
2018 Q4	$31.3M	Buy	1,142,071 +433,194	+61%	+$11.2M	﹤0.01%	1372
2018 Q3	$20.7M	Buy	+708,877	New	+$20M	﹤0.01%	1668

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return

Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ADL

Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Fidelity Investments's PRNB Position: Q3 2020 in Review

Fidelity Investments sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 4,956,097 shares — an estimated $296M sold.

Fidelity Investments first reported a position in PRNB in Q3 2018 and held it in 8 quarters. The position peaked at $296M in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

Fidelity Investments reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Fidelity Investments sold 4,956,097 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $296M.
Fidelity Investments first reported a position in Principia Biopharma Inc. Common Stock in Q3 2018 and held it in 8 quarters.
Fidelity Investments's Principia Biopharma Inc. Common Stock position peaked at $296M in Q2 2020.
9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Fidelity Investments's 13F filing for Q3 2020, filed 13 Nov 2020.